Latest filing published 06 Mar 2023 for NGM Biopharmaceuticals INC.
Filing timeline
BuySaleInsider track record
Jin-Long Chen: trading record in brief
All filings by Jin-Long Chen on record concern NGM Biopharmaceuticals Inc. Between 31 October 2019 and 2 March 2023, the trades on record add up to 55 filings.
On the market, this insider has only sold: 41 sales, €10.4M in total. Other entries cover 1 share grant and 13 option exercises. So far in 2023, the count stands at no purchases and 1 sale.
On 6 March 2023 came the latest disclosure, a share grant in NGM Biopharmaceuticals Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Jin-Long Chen
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 64,000 shares0Common StockSEC:0001209191-23-016384:0
- 85,082 shares@ US$5.153.7% of flowCommon StockSEC:0001209191-23-003702:1
- 85,082 shares@ US$1.446.4% of flowCommon StockSEC:0001209191-23-003702:0
- 69,444 shares@ US$1.440.8% of flowCommon StockSEC:0001209191-21-068466:1
- 15,000 shares@ US$18.602.3% of flowCommon StockSEC:0001209191-21-068466:2
- 15,000 shares@ US$18.2113.6% of flowCommon StockSEC:0001209191-21-068466:0
- 15,000 shares@ US$19.562.4% of flowCommon StockSEC:0001209191-21-064853:1
- 15,000 shares@ US$19.8914.7% of flowCommon StockSEC:0001209191-21-064853:0
- 15,000 shares@ US$20.142.5% of flowCommon StockSEC:0001209191-21-060364:1
- 15,000 shares@ US$20.4114.9% of flowCommon StockSEC:0001209191-21-060364:0
- 10,910 shares@ US$26.172.3% of flowCommon StockSEC:0001209191-21-056083:1
- 170 shares@ US$26.980.0% of flowCommon StockSEC:0001209191-21-056083:2
- 11,963 shares@ US$25.542.4% of flowCommon StockSEC:0001209191-21-056083:3
- 3,037 shares@ US$26.130.6% of flowCommon StockSEC:0001209191-21-056083:4
- 3,920 shares@ US$25.594.8% of flowCommon StockSEC:0001209191-21-056083:0
- 6,669 shares@ US$25.121.3% of flowCommon StockSEC:0001209191-21-050981:1
- 600 shares@ US$25.620.1% of flowCommon StockSEC:0001209191-21-050981:2
- 15,000 shares@ US$23.152.8% of flowCommon StockSEC:0001209191-21-050981:3
- 7,731 shares@ US$23.818.8% of flowCommon StockSEC:0001209191-21-050981:0
- 69,444 shares@ US$1.444.6% of flowCommon StockSEC:0001209191-21-038655:0
- 25,000 shares@ US$27.6232.2% of flowCommon StockSEC:0001209191-21-029913:0
- 25,000 shares@ US$24.654.9% of flowCommon StockSEC:0001209191-21-026503:0
- 25,000 shares@ US$26.665.2% of flowCommon StockSEC:0001209191-21-016231:0
- 25,000 shares@ US$28.755.6% of flowCommon StockSEC:0001209191-21-011253:0
- 24,630 shares@ US$29.275.6% of flowCommon StockSEC:0001209191-21-002374:0
25 of 55 declarations